DAVID GRANOVSKY

Mayo Clinic + stem cell biotech

In STEM CELLS IN THE NEWS on September 2, 2009 at 11:45 am

Kiger’s Notebook – By Jeff Kiger, Post-Bulletin business columnist

September 01, 2009

Mayo Clinic-linked stem cell biotech = “Tremendous potential”

I’ve written about Cardio3, a Belgium biotech that is using Mayo Clinic research as part of its stem cell-based cardiac treatment, a few times before here and here.Today the company kicked out a release about its presentation at the European Society of Cardiology Congress in Barcelona, Spain. Here a little from the release:

————–

A unique second generation stem-cell derived therapy, C-Cure allows the differentiation of a patient’s own cells into ‘cardiopoietic’ cells which grow into new heart cells and repair heart muscle. C-Cure is currently undergoing a randomized, multi-center pivotal trial, designed to evaluate the safety and efficacy beyond optimal clinical care in patients with heart failure…

via Postbulletin.com: Rochester, MN.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: